Feasibility of his bundle pacing as an alternative pacing site: measurement of his refractoriness.
BACKGROUND
Direct pacing of the His bundle has been proposed for permanent pacing to maintain physiological synchrony of ventricular activation. Measurement of His bundle refractoriness may be useful in predicting suitability of this technique in an individual. We sought to determine whether this could be measured consistently in patients, defining a normal range.


METHODS
His bundle pacing was performed in 20 consecutive patients (mean age 44.6 +/- 19.5, 5 male) undergoing electrophysiology study. Incremental and extrastimulus testing were performed from the His region to determine effective and functional refractory periods of the His bundle.


RESULTS
Consistent His capture was possible in 18 of 20 (90%) patients studied. Extrastimulus testing from the His region at a drive cycle length of 600 msec was successful in all of these patients. With loss of His capture, QRS duration prolonged 32%, and stimulus to atrial electrogram interval prolonged 49.6 +/-16.3 msec. The effective refractory periods at drive cycle lengths 600, 500, and 400 msec were 407 +/- 70 msec, 320 +/- 39 msec, and 336 +/- 54 msec, respectively. Corresponding functional refractory periods were 414 +/- 62, 371 +/- 52, and 329 +/- 32. Consistent capture with incremental His pacing was possible in 50% of patients, and 1:1 His capture was lost at mean cycle length 408 +/-93 msec.


CONCLUSIONS
His refractory periods can be determined consistently in unselected individuals undergoing electrophysiological studies. Measurement of HERP and HFRP may prove useful in assessing the suitability of the His bundle for permanent pacing.
Gula
Lorne J
LJ
Division of Cardiology, University of Western Ontario, London, Ontario, Canada.
Trim
Geoffrey M
GM
Krahn
Andrew D
AD
Skanes
Allan C
AC
Yee
Raymond
R
Klein
George J
GJ
D000328:Adult; D002036:Bundle of His / Q000503:physiopathology*; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004562:Electrocardiography; D005240:Feasibility Studies; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged
J Am Coll Cardiol. 1994 Jul;24(1):225-32
8006270
Pacing Clin Electrophysiol. 1999 Sep;22(9):1372-7
10527019
Circulation. 1985 May;71(5):1010-6
3986971
Lancet. 1997 Oct 25;350(9086):1210-6
9652562
Pacing Clin Electrophysiol. 1999 Dec;22(12):1777-81
10642131
Am Heart J. 1988 Jul;116(1 Pt 1):16-22
3394616
J Am Coll Cardiol. 1997 Mar 15;29(4):744-9
9091519
J Am Coll Cardiol. 2003 Apr 2;41(7):1218-26
12679225
JAMA. 2002 Dec 25;288(24):3115-23
12495391
Circulation. 2000 Aug 15;102(7):736-41
10942740
Circ Res. 1983 Jul;53(1):72-85
6861298
Circulation. 2000 Feb 29;101(8):869-77
10694526
Circulation. 1996 Sep 1;94(5):1027-35
8790042
N Engl J Med. 2002 Jun 13;346(24):1854-62
12063369
Rev Esp Cardiol. 2001 Dec;54(12):1385-93
11754807
Am J Cardiol. 1964 Oct;14:494-503
14215060
J Am Coll Cardiol. 2001 Jul;38(1):167-72
11451268
J Am Coll Cardiol. 1993 Apr;21(5):1124-31
8459065